We designated “ImmunoGenic Surrender” (IGS), the mechanism whereby CXCR4 engagement drives CD47 surface depletion and eventually the appearance of tumor-specific CD8 T cell clones, as the tumor cells surrender to macrophages, which phagocytose them when still alive [75]. The gene discussed is CXCR4; the disease is neoplasm.